ARCHIVES

FDA Hazleton Probe Finds Some Problems; Results Unaffected

This article is from The Cancer Letter archive.

Vol. 02 No. 17 | April 23, 1976

Download PDF Visit The Full Archive

Related Articles

Zometa Can Reduce Risk Of Skeletal-Related Events

August 26, 2011

Two Cooperative Groups Renamed ECOG-ACRIN

September 23, 2011

In Brief: GM awards Shared By Six Scientists; Pollard Named President of Salk Institute

June 21, 1996

Genetic Test Identifies Patients With High Risk of Mortality

November 30, 2012

Illinois Cancer Center Closes Following Veto of State Funds; Was First Consortium Center

December 11, 1992

Colon Cancer Survival Rates Differ Across Racial Lines

October 28, 2011